This comes after the European Union launched a scheme that could block exports of coronavirus vaccines.

The U became entangled in a row with drugmaker AstraZeneca.

You health authorities approved the company's job on Friday, but Brussels says it has failed to supply the vaccine in the quantities promised and says the controls are needed to ensure export orders aren't fulfilled.

First, it was a dramatic decision born out of desperation.

Faced with diminished deliveries of the covert 19 vaccine, you on Friday announced controls on vaccine exports.

This threatened controls at the border between the Republic of Ireland and Northern Ireland.

Keeping the border open was a key you demand in the drawn out Brexit.

Negotiations on the news was greeted with disbelief In the UK You know, I think it's quite incredible.

It's an act of aggression, actually, less than a month into us leaving the European Union, we see them act in this unilateral way.

The move came as the World Health Organization expressed concern over resource nationalism.

It's not helpful to have any country at this stage putting export bands or barriers that will not allow for the free movement off the necessary ingredients that will make vaccines diagnostics in other medical since available toe all the world the U swiftly wrote back, making clear that the island UK border would remain open but controls the vaccine exports will remain in place.

The measure was prompted by drugmaker AstraZeneca, which plans to delay deliveries of its vaccine to the U while maintaining full deliveries to the U.

K This is a race against the clock.

We cannot lose time because of vaccines not being delivered on agreed schedule.

Uh, To achieve this, we need to ensure that all advanced purchase agreements for vaccines made by the European Union on our honor.

The row has not stopped the use European Medicines Agency from approving AstraZeneca's vaccine for use within the union.

But with the producer unwilling to significantly ramp up the blocks deliveries, the approval is unlikely to boost on immunization campaign that is struggling to get off the ground.

Well, for more on this, we're joined now by Rasmus Hansson is the CEO of Air Affinity, a science information and analytics company.

Welcome to the program, Mr Hansen.

Why is the European Union struggling to secure its vaccines Well, Well, the EU has has made some wrong bets early on, in, in, in, in, in, in the pandemic.

They haven't scaled up production in at the same speed as as other countries have been later to make the deals and and therefore they are having more supply issues than than the UK and also the US At the moment on, how will these export controls affect the use vaccine supply?

Well, I I think the problem is that with these controls, everyone loses out right, because you have to look at the broader than just export off finished vaccine, right?

That goes a lot of ingredients into the vaccines in the first place that come from all over the world.

You need syringes, you need wild vials.

And also you need feeling finished in other places.

So the moment we don't have a free flow of medicine across borders, the whole production will actually is at risk of being being Hold it.

So I think it won't benefit you a lot.

You know, they will get maybe a little bit more off the FISA vaccines if they stopped the Belgian plant for exporting that to the U.

K.

But we're talking 30 million and you know, with the with the you use population, that's not going to make a huge difference.

Now the W H O is also worried about the effects that this will have on vaccine production not just in Europe but of course, globally.

On how will the rest of the world be affected by thes vaccine export controls?

Well, so so, so short term.

I think you know that that there isn't a lot of exports going on yet at the moment, most countries actually tend to use their own domestic production.

But longer term, this is an incredibly dangerous to take a country like India.

India is set to produce several billions of vaccines.

If India starts saying we're not going to export any of that, then the whole Kovacs many low and middle income countries will be hugely at risk and also going back to the U.

If you look at per capita perspective, EU doesn't actually have a lot of production inside the EU for approved vaccines.

US has many more UK has more and also country like Switzerland, the you might be dependent on it already is for the Madonna import.

So you is also longer term, actually, risking having some of its own issues so so short term and won't make a big difference.

And long term, it really puts.

Puts the whole world at risk.

Rasmus Hansson Off analytics Company Air Affinity.

Thank you.